According to Samsung Biologics 's latest financial reports the company's current revenue (TTM ) is HK$24.41 Billion. In 2023 the company made a revenue of HK$21.91 Billion an increase over the revenue in the year 2022 that were of HK$17.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.